Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Nature Cell Biology
|
October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size
Lara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology
|
March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Ainhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology
|
May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial
Cynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell
|
April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo
Kenji Namoto, Clara Baader, Vanessa Orsini, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Nature Cell Biology
|
October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size
Lara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology
|
March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Ainhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology
|
May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial
Cynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell
|
April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo
Kenji Namoto, Clara Baader, Vanessa Orsini, et al.
Page
of 8